Matches in Nanopublications for { ?s ?p "[Both MYO9B rs7259292 and HLA-DQ2 homozygosity increase the risk for RCD II and EATL to a similar extent when compared with uncomplicated CD patients (OR, 4.3; 95% CI, 1.9-9.8 and OR, 5.4; 95% CI, 3.0-9.6, respectively), but there was no evidence for any interaction between these 2 risk factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion description "[Both MYO9B rs7259292 and HLA-DQ2 homozygosity increase the risk for RCD II and EATL to a similar extent when compared with uncomplicated CD patients (OR, 4.3; 95% CI, 1.9-9.8 and OR, 5.4; 95% CI, 3.0-9.6, respectively), but there was no evidence for any interaction between these 2 risk factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_provenance.
- NP651034.RArx8dJ1Ve-ARn9PT2YG4RcdGp4il7E_O1NkeWqVeoeZE130_assertion description "[Both MYO9B rs7259292 and HLA-DQ2 homozygosity increase the risk for RCD II and EATL to a similar extent when compared with uncomplicated CD patients (OR, 4.3; 95% CI, 1.9-9.8 and OR, 5.4; 95% CI, 3.0-9.6, respectively), but there was no evidence for any interaction between these 2 risk factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651034.RArx8dJ1Ve-ARn9PT2YG4RcdGp4il7E_O1NkeWqVeoeZE130_provenance.